Last reviewed · How we verify

NCT06728007

Nephrological Outcome and Associated Congenital Anomalies in Pediatric Patients with Horseshoe Kidney

Recruiting now Last updated 11 December 2024
What this trial tests

trial in Horseshoe Kidney in 500 participants. Currently enrolling.

Timeline
1 June 2025
Primary endpoint
1 June 2026
1 June 2026

Quick facts

Lead sponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date1 June 2025
Primary completion1 June 2026
Estimated completion1 June 2026
Sites1 location across Italy

Conditions studied

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna — full company profile →

Who can join

Under 18, any sex, with Horseshoe Kidney. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A retrospective, observational multicentre trial on the nephrological outcome and associated congenital anomalies in children with Horseshoe Kidney.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other IRCCS Azienda Ospedaliero-Universitaria di Bologna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06728007.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing